Quest for Novel Regenerative Medicine and Changes in Government Regulations Brighten Stem Cell Research Prospects, according to an Exclusive Report from RI Technologies.
Hyderabad, AP (PRWEB) July 16, 2012
Stem Cell Research has picked up pace like never before now. The science of stem cells is leading to evolution of cell-based therapies referred to as reparative or regenerative medicine for the treatment of diseases. The ongoing research on stem cells indicates the replenishment of damaged cells by healthy cells in adult organism and the origin of an organism through a single cell. Stem cell science is predicted to be the most promising field in Biology though it has its own share of queries and controversies.
Stem Cell Research is progressive yet mired in controversies. The technology is leading to a new kind of cell-based medicine that is regenerative in nature. However, practicality and ethics dominate the ever controversial subject. Hence, it may take some more time, before a proper worldwide consensus emerges on the usage and procedures of stem cell research. While some countries approve, some oppose. Stem cell research is most likely to gather pace in countries with less regulatory controls. Of all the countries, China has the most favorable environment for research. The UK too has a strong research presence. The United States is the leader in stem cell research. However, the government controls the grants for research but places no restrictions on funds from private, state, or local government resources.
Stem cells give advanced information about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. This is a very promising area of science and has huge disease-curing applications. Stem cells are as much part of controversy as they are exciting. They possess the potential for curing diseases including Alzheimers, Diabetes, Huntingtons and Parkinsons. Stem cell research itself is controversial as the stem cells are derived from embryos. Growth of stem cells market worldwide is basically driven by the potential of stem cells for the various diseases. For example, embryonic stem cells are capable of generating new tissues and organs to replace the damaged tissues and organs.
Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. The US is the leader followed by the European and Asia-Pacific regions. With government regulations being amended in several countries, Stem Cell Research is expected to pick up pace rapidly in the next few years.
Stem Cell technology is being increasing applied for the past decade to treat critical diseases and presently utilized for treatment of more than 70 diseases. Utility of stem cells in cosmetic and post injury healing therapy was also established recently. Umbilical cord is an abundant source of stem cells and the best advantage of this source is that it is a non-invasive procedure as cord blood and cord tissue are utilized to derive stem cells.
Stem cells are found in adult bone marrow and also in embryos. Adult stem cells have been used in disease treatment since long time. However, embryonic stem cell research is the topic of debate. The field can lead to great therapeutic treatments. But, due to its various ethical origins, is mired in debates all over the world. Embryonic stem cells have the potential to transform into any other type of cell (unlike adult stem cells). The huge potential for embryonic stem cells lies in finding treatments for liver disorders, neurodegenerative disorders, spinal cord injuries, cardiac diseases, cancers, diabetes, cosmetics, bone and cartilage diseases, ostroarthritis, rheumatoid arthritis, and a host of other life threatening diseases. The discovery of a second source of adult stem cells has given hope and great potential for the future of stem cell therapy.
Embryonic stem cell research evokes great excitement primarily due to the fact that embryonic stem cells can make so called regenerative medicine and be used in therapeutic cloning. Embryonic stem cell research has the potential to contribute to the management and treatment of a large number of diseases such as diabetes, spinal cord injuries, cardiac disease, Parkinsons and Alzheimers disease. Scientists can learn about human cell growth and development, and also to understand cancer better. However, controversial debates (ethical issues) in this area have led scientists to study more about adult stem cell research. However, embryonic stem cells still capture scientists fancy due to their enhanced proficiency at cell division and plasticity. Apart from the US (after initial bans), the UK, Belgium, Sweden, Japan, China and South Korea have allowed embryonic stem cell cloning. The EU also provides funds for countries undertaking embryonic stem cell research. President Obamas change in policy for embryonic stem cell research will open new doors for scientists. A lifting of restrictions also means that detailed guidelines have to be outlined and proper laws should be in place for the several issues in stem cell research.
Countries are competing globally for getting an edge in stem cell research as breakthrough technologies in this field would herald the countrys medical expertise and dominance. Research and laboratory technologies are also progressing rapidly. The potential of stem cell research both medically and economically, is leading to huge investments by biotechnology companies, pharmaceutical companies and governments too.
For more information about this report, please visit: http://www.researchimpact.com/MIR005_STEMCELLRESEARCH.aspx
Customer Support: contactus(at)researchimpact(dot)com.
Phone: +91 9676994272 / UK: 076-24-057837 for 24/7 online and offline support.
About RI Technologies
RI Technologies, http://www.researchimpact.com, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company’s reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies’ research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.
Psoriatic Arthritis – A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet R
xxsurl.com Psoriatic Arthritis – A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References – Icon Health Publications This is a 3-in-1 reference book. It gives a complete medical dictionary covering hundreds of terms and expressions relating to psoriatic arthritis. It also gives extensive lists of bibliographic citations. Finally, it provides information to users on how to update their knowledge using various Internet resources. The book is designed for physicians, medical students preparing for Board examinations, medical researchers, and patients who want to become familiar with research dedicated to psoriatic arthritis. If your time is valuable, this book is for you. First, you will not waste time searching the Internet while missing a lot of relevant information. Second, the book also saves you time indexing and defining entries. Finally, you will not waste time and money printing hundreds of web pages.Author: ICON Health Publications Publisher: ICON Health Publications Illustration: N Language: ENG Title: Psoriatic Arthritis – A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References Pages: 00000 (Encrypted PDF) On Sale: 2004-04-27 SKU-13/ISBN: 9780597845666 Category: Health & Fitness : Diseases – Musculoskeletal This is a 3-in-1 reference book. It gives a complete medical dictionary covering hundreds of terms and expressions relating to psoriatic arthritis. It also gives extensive lists of bibliographic …
Dogs with elbow arthritis needed for vet research project
Dogs with elbow arthritis needed for vet research project
Similar supplements are commonly purchased and consumed by human patients suffering with chronic osteoarthritis also known as "long-term arthritis”. The nutrient combination in the research formulation acts as a COX-2 inhibitor; similar to over the …
Read more on WSU News
Reflecting on Arthritis Pain: New Therapy Offers Promise
In an as-yet unpublished study, researchers at the University of California at San Diego applied the mirror technique to patients with osteoarthritis or rheumatoid arthritis. The scientists overlaid the image of a healthy hand over the sufferer's …
Read more on ABC News
Hot and Cold Topical Therapy Manufacturing in the US Industry Market Research Report Now Available from IBISWorld
Los Angeles, CA (PRWEB) June 13, 2012
The Hot and Cold Topical Therapy Manufacturing industry has been resilient during the five years to 2012, with revenue expected to increase 2.1% annually on average to $ 1.3 billion during the period. According to IBISWorld industry analyst Sophia Snyder, This moderate revenue growth has mainly been due to product advancements, the aging population and regulatory standards that require the use of certain industry products. Guidelines for professional use of certain industry products were put in place in 2005, but more physicians have been following the recommendations during recent years, which has enhanced demand. Additionally, the Centers for Medicare and Medicaid implemented standards to use certain hot and cold therapies in 2009. More research continues to be conducted to demonstrate the treatment and cost benefits of hot and cold therapies for use in professional (i.e. hospital) settings and by individual users.
The Great Recession reduced disposable income, which in turn curbed spending among consumers on hot and cold topical therapies that are used for home-based and self-provided care. In contrast, the professional healthcare market grew during the recession. Hot and cold therapies have been shown to lower total costs in this market by reducing infections and other complications. As healthcare providers looked for methods to reduce spending during the recession, says Snyder, the industry’s progressively effective products grew in appeal. In 2012, the Hot and Cold Topical Therapy Manufacturing industry is expected to get a boost from the combination of the improving economic environment and continuing cost pressures in the provider market. During the year, growth is expected to accelerate to 2.5%. The top three players in the industry Stryker Corporation, CR Bard Inc. and Zoll Medical Corporation together account for less than a quarter of this fragmented industry’s revenue.
The aging population and rising disposable income is forecast to bolster demand during the five years to 2017; during this time, revenue is projected to grow. Meanwhile, the professional healthcare market is forecast to pressure prices for industry products as hospitals and other providers move toward larger practices. This trend will encourage further consolidation within the industry, as larger manufacturers will be better equipped to negotiate with bigger healthcare providers. During the five years to 2017, the number of operators is forecast to decrease. Despite consolidation, industry profitability is forecast to decrease slightly due to the implementation of a medical device tax on many industry operators as part of healthcare reform legislation. For more information, visit IBISWorlds Hot and Cold Topical Therapy Manufacturing in the US industry report page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
IBISWorld industry Report Key Topics
This industry manufactures devices, including pouches and sacks, that provide therapy for issues like arthritis, cold tumors, poliomyelitis, pelvic diseases, malignant ulcers, homeostasis, analgesic, soft tissue inflammation and other ailments.
Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios
About IBISWorld Inc.
Recognized as the nations most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Sonora Clinical Research Psoriatic Arthritis
A Clinical Trial for Psoriatic Arthritis sufferers in Boise and surrounding areas.
Video Rating: 0 / 5
Achieve Clinical Research Is Conducting New Rheumatoid Arthritis Trials in Birmingham, Alabama
Birmingham, Alabama (PRWEB) April 09, 2012
Achieve works with the worlds leading pharmaceuticals like Pfizer, Novartis, Astra Zeneca, Eli Lilly and more. The medical researchers at Achieve Clinical Research facility have started the enrollment process for this new Rheumatoid Arthritis (RA) clinical study and are currently seeking individuals who fit the Key Inclusion Criteria. Individuals who have been diagnosed with RA, should read on to see how you can participate in this new study.
HOW TO PARTICIPATE —
To find out more about getting involved, please call (205) 757-8212 or click the link to learn more about participating in a Rheumatoid Arthritis Clinical Trial!
KEY INCLUSION CRITERIA —
In order to be eligible for this study, there are some key criteria that participants need to meet:
-Presence of rheumatoid arthritis as classified by the American College of Rheumatology revised criteria for early diagnosis.
-At the time of the screening, eligible participants need to test positive for anti-CCP antibodies or rheumatoid factor.
-Eligible participants need to be on a stable dose of MTX for at least 4 weeks before the clinical trial and experiencing inadequate control of the rheumatoid arthritis.
KEY EXCLUSION CRITERIA —
There are also a number of criteria which can exclude a person from taking part in this clinical study, including:
-Anyone who takes any type of other investigational drug within 30 days of the study will not be eligible.
-Anyone who has been shown to be allergic or hypersensitive to any of the substances being used in the study will be prohibited.
-Any patients who are already taking some form of high potency opioid (such as methadone or morphine).
-Any patient who has been experiencing any other form of inflammatory disease which may skew the effective valuation of the investigational therapy.
-Anyone who has a history of significant liver disease or liver injury.
ABOUT THE STUDY —
Dr. David McLain, Achieves principal investigator of this study will be testing the tolerability, safety, and efficacy of this new therapy. The results in this group will be compared to a control group.
CLINICAL TRIAL FACILITY OVERVIEW —
Achieve Clinical Research is a part of the Accel Research Company, and conducts clinical trials in Birmingham Alabama. The Achieve clinical trial facility is located at the center of the medical corridor of the city, which also allows the Achieve medical staff exclusive hospital privileges. The medical professionals at Achieve Clinical Research can conduct phase 2 – 4 clinical trials at their facility. This clinical trial facility is fully equipped with state of the art medical equipment and an on-site patient recruitment center. The medical team at Achieve Clinical Research prides itself on being able to provide rapid start ups, efficient project management, and complete protocol achievement. Volunteers who take part in a clinical study at Achieve Clinical Research will receive compensation for their time and any necessary travel expenses. All study related care which includes physical examinations, study medications, and laboratory services will be provided for participants free of charge.
ABOUT RHEUMATOID ARTHRITIS —
It is estimated that around 2.1 million people in the United States suffer from the symptoms of rheumatoid arthritis. That is almost 1% of the American population. This is a painful autoimmune disease which has been characterized by the severe inflammation it causes. Most commonly people get rheumatoid arthritis in the smaller joints of their wrist or fingers, but this condition can affect any joint in the body. Research has shown that women between the ages of 25 and 55 years old are at a higher risk of developing rheumatoid arthritis in their joints. This condition also tends to range in severeness. For many patients, they may have it for only a short while, while the more severe cases can last a lifetime. The exact cause of rheumatoid arthritis is still largely unknown, but doctors have attributed a number of factors to the disease such as genes, hormones, and the environment.
PRINCIPAL INVESTIGATOR —
The principal investigator for this clinical study is David McLain MD. Dr. McLain received his medical education at Tulane University in New Orleans, LA. After graduation he completed his residency at the Barnes Hospital located in St. Louis, MO. He then went on to complete a fellowship in Rheumatology at the Washington University School of Medicine. Dr. McLain lives in Birmingham, AL where he is board certified in Rheumatology and Internal Medicine.
HOW TO PARTICIPATE —
If someone you know has Rheumatoid Arthritis and would like to find out more about this trial, please call (205) 757-8212 or visit http://www.achieveclinical.com/clinical-trials/rheumatoid-arthritis/ to learn more about participating!
The Arthritis Research UK Garden for RHS Chelsea Flower Show 2012
The Arthritis Research UK Garden RHS Chelsea Flower Show 22nd – 26th May 2012 Arthritis Research UK is to stage one of the major show gardens at RHS Chelsea Flower Show 2012. The garden will be used as a platform to promote the charity’s work in highlighting the great impact arthritis has on so many lives of people in the UK. The Arthritis Research UK Garden has been designed by award-winning landscape and garden designer Tom Hoblyn. His creation is inspired by the great Renaissance gardens of Italy, capturing the drama, formality and beauty of these historic gardens, whilst indulging his passion for creative planting. The garden’s Renaissance theme was devised by Arthritis Research UK to symbolise its own ‘rebirth’ with a new brand and future goals as it marks its 75th anniversary. The garden explores the fascinating theory of man controlling nature and demonstrates the divine proportions and perfect symmetry of the gardens of the Renaissance period. Using water as a central theme, the garden incorporates three spectacular water features – a fountain seat, a water cascade and a still mirror pool – set amongst formal Mediterranean planting, with five majestic cypress trees providing a stunning backdrop. Although the garden was not designed specifically for people who suffer from arthritis there are some wonderful elements that demonstrate practical ways of making gardening easier, including raised beds, gently sloping paths and the inclusion of herbs such as borage that …
How does gout affect your foot?-Minnesota Podiatrist Explains www.innovativefootcare.com www.innovativefootcare.com 1 (507) 532-4676 Minnesota Podiatrist Dr. DeBrule explains how gout affects your foot. Minnesota Podiatrist] Dr. Mike DeBrule treats foot problems that can cause [foot,ankle,…
Video Rating: 5 / 5
Iverson Sponsors Run/Walk for Psoriatic Arthritis: Area Businesses and Community Support Research for a Cure
Milwaukee, WI (PRWEB) September 22, 2005
Iverson Language Associates, Inc. was one of several sponsors of the second annual Michael Tarney Run/Walk for Psoriatic Arthritis. The event, which took place on September 10th in Milwaukee, raised over $ 20,000 for the 1.1 million people in Wisconsin affected by arthritis and related diseases.
The proceeds of the event will support ongoing research to cure the many forms of arthritis, especially psoriatic arthritis.
The Wisconsin Chapter of the Arthritis Foundation, and Michael Tarney, a local restaurant owner, were the leading co-sponsors of the event, along with many area businesses.
I want people to realize how devastating this disease can be, said Tarney. But I also want them to know that there is hope and, by working together, we increase our chances of finding the cures that will change lives for so many people.
Last years event raised over $ 10,000 for the 1.1 million people in Wisconsin affected by arthritis. This year, there was a 100% increase in donations from area businesses, individuals and families. This level of response is very encouraging; were glad to be involved in this event to support ongoing research in an effort to find a cure, said Steve Iverson, President/CEO of Iverson Language Associates, Inc.
More information about the Arthritis Foundation can be found at http://www.arthritis.org.
Information on Iverson Language Associates, Inc. can be found at http://www.iversonlang.com.
###
Ayurveda Hospital & Research Centre in Pondicherry, India Looking for Franchisee in Europe–We Relieve STRESS, Detoxify the body, Help Nervous Problems–No Side Effects
(PRWEB) April 19, 2006
Rosema Ayurveda Hospital and Research Centre has been established in Pondicherry with the sole mission of popularising Ayurveda as an holistic health care system. Here you will discover the amazing healing power of a natural healthcare system 300 years old. It is based on the concept of “Perfect Health” and the complete knowledge of life.
The total understanding of the human body and the ability to harness the healing powers of nature has enabled quality practice and client care. Realising the mystical creative and regenerative powers of Ayurveda. We resort to this treatment to offer a new lease of life.
We believe in rejuvenation of the individual as a whole to eliminate all toxic imbalances in the body, cleansing and curing the ailment and attaining a complete balance of body and soul, senses and the mind. It is practiced in a systematic and scientific method by the manipulation of body tissues with medicated oils as per individual diagnosis under the supervision of eminently qualified physicians and therapists.
It is set amidst coconut palms amongst a variety of medicinal plants and trees that help to bring the mind and body to rest in its tranquility. A well landscaped lawn and a herb garden directly providing for restorative treatments offer a calm and soothing atmosphere. The environment helps to prepare oneself mentally; to become relieved of tension and become fully cured.
Herbal ingredients including toiletries are used exclusively. It continues to promote the ayurvedic concepts of ‘Man with and of Nature.’
SPECIALITY TREATMENT
Cervical Spondylosis – Cervical spondylosis is a common degenerative condition of the cervical spine that most likely is caused by age-related changes in the intervertebral disks. Clinically, several syndromes, both overlapping and distinct, are seen: neck and shoulder pain, suboccipital pain and headache, radicular symptoms, and cervical spondylotic myelopathy (CSM). As disk degeneration occurs, mechanical stresses result in osteophytic bars, which form along the ventral aspect of the spinal canal.
Frequently, associated degenerative changes in the facet joints, hypertrophy of the ligamentum flavum, and ossification of the posterior longitudinal ligament occur. All can contribute to impingement on pain-sensitive structures (nerves and spinal cord), thus creating various clinical syndromes. Spondylotic changes often are observed in the aging population. However, only a small percentage of patients with radiographic evidence of cervical spondylosis are symptomatic.
Lumbar Spondylosis – Lumbar spondylosis describes bony overgrowths (osteophytes), predominantly those at the anterior, lateral, and, less commonly, posterior aspects of the superior and inferior margins of vertebral centra (bodies). This dynamic process increases with, and is perhaps an inevitable concomitant, of age Lumbar spondylosis usually produces no symptoms. When back or sciatic pains are complaints, lumbar spondylosis usually is an unrelated finding.
Spondylolisthesis – spondylolysis stress fracture in one of the bones (vertebrae) that make up the spinal column is called spondylolysis (spon-dee-low-lye-sis). It usually affects the fifth lumbar vertebra in the lower back, and much less commonly, the fourth lumbar vertebra.If the stress fracture weakens the bone so much that it is unable to maintain its proper position, the vertebra can start to shift out of place. This condition is called spondylolisthesis.
IVDP – Inter Vertebral Disc Prolapse commonly caused due to over strain, weakness of spinal muscles, due to technically incorrect exertion and exercises and some pathological conditions.
Rheumatic Disorders – The words rheumatism and the rheumatic diseases are still sometimes used in order to describe a whole range of different conditions which affect the muscles, tendons, joint tissues and other non-joint tissues of the body. The one thing that all these disorders have in common is that they cause pain!
Polymyalgia Rheumatica in this disorder there is pain and stiffness in a lot of different muscles, especially those around the shoulders. It affects mainly the elderly.
Tenosynovitis This is an inflammation of the sheathes of the tendons they are the cord-like structures in the wrist and elsewhere, which many older people call leaders. Injections and manipulation may help.
Capsulitis this is an inflammation of the capsule (the covering) of the joint, often the shoulder.
Bursitis This is an inflammation caused by friction between soft tissues and underlying bone.
Allergic Disorders – The respiratory allergy is the form which is found more and which might lead to Allergic Asthma. In such cases low immunity leads to recurrent respiratory infections and to fatal condition.
Obesity – The condition of being significantly overweight. It is usually applied to a condition of 30 percent or more over ideal body weight. Obesity puts a strain on the heart and can increase the chance of developing high blood pressure and diabetes.
Psoriasis – Psoriasis is a chronic scaling disease of the skin. It may range from just a few spots anywhere on the body to large areas of involvement. It is not contagious or spreadable from one part of the body to another or from one person to another.
There is no blood test for psoriasis. The diagnosis is made by observation and examination of the skin. Sometimes microscopic examination of the skin (biopsy) is helpful where the changes are not typical or characteristic.
The exact cause of psoriasis is unknown, but hereditary and genetic factors are important. Psoriasis runs in families. This does not mean, however, that every child of a parent with psoriasis will develop psoriasis, but it is common that somewhere down the line psoriasis will appear in families. Psoriasis is not caused by allergies, infections, dietary deficiencies or excesses, or nervous tension.
Psoriasis does not affect the overall general health. If it is widespread it can certainly cause a great deal of skin discomfort and emotional embarrassment, and can affect job and leisure time activities. Fortunately most people who have psoriasis only have a small amount and while it certainly can be a nuisance, it does not alter the lifestyle.
people with psoriasis there can develop a form of arthritis called psoriatic arthritis. It will take proper medical examination to confirm this diagnosis. Although not always, psoriatic arthritis is more often seen in people with widespread psoriasis than those who have a small amount. The psoriatic arthritis can affect people of all ages
Post Natal Care – Ayurveda suggests some special medication and therapies after delivery to maintain body strength and to bring back the normal condition of abdomen and internal organs.
2.HEALTH CARE PROGRAMME
Rejuvenation Therapy – ( Rasayana Chikilsa) – This treatment includes body massage with hand & foot by medicated oil , head massage and face massage with oil and cream , internal rejuvenative medicines and medicated steam bath. This therapy is to rejuvenate mind, body and soul, to tune up skin , to strengthen all systems so as to achieve ideal health and longevity.
Body Purification Theraphy – ( Shodhan Chikilsa) – It is a process of purifying the whole body to attain proper balance of vatha , pitha and kapha based on panchakarma and swetha karma treatment . The process includes body massage,shehapanam, vamanam , nasyam , virechanam , medicated purgative , sneha vasthi, pizhichil , gnavarakizhi tharpanam (cleaning the eyes), sirovasthi and steam bath.
Body Immunisation Treatment – This is the prime treatment in Ayurveda for reducing ageing process, arresting the degeneration of body cells and immunization of the system. Giving rasayana, (very spec
What help does Arthritis Research UK provide to people with Arthritis?
The different ways we help people diagnosed with arthritis. Read more at www.arthritisresearchuk.org